p16 mutation spectrum in the premalignant condition Barrett's esophagus.
Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the...
Hlavní autoři: | Thomas G Paulson, Patricia C Galipeau, Lianjun Xu, Heather D Kissel, Xiaohong Li, Patricia L Blount, Carissa A Sanchez, Robert D Odze, Brian J Reid |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Public Library of Science (PLoS)
2008-01-01
|
Edice: | PLoS ONE |
On-line přístup: | http://europepmc.org/articles/PMC2585012?pdf=render |
Podobné jednotky
-
NSAIDs modulate clonal evolution in Barrett's esophagus.
Autor: Rumen L Kostadinov, a další
Vydáno: (2013-06-01) -
NSAID use and somatic exomic mutations in Barrett’s esophagus
Autor: Patricia C. Galipeau, a další
Vydáno: (2018-02-01) -
Correction to: NSAID use and somatic exomic mutations in Barrett’s esophagus
Autor: Patricia C. Galipeau, a další
Vydáno: (2019-03-01) -
Within‐patient phylogenetic reconstruction reveals early events in Barrett’s Esophagus
Autor: Lucian P. Smith, a další
Vydáno: (2021-02-01) -
High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.
Autor: Amitabh Srivastava, a další
Vydáno: (2015-01-01)